Cargando…

Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo

Lansoprazole (Lpz) is an FDA-approved proton pump inhibitor (PPI) drug for the therapy of acid-related diseases. Aiming to explore the new application of old drugs, we recently investigated the antitumor effect of Lpz. We demonstrated that the PPI Lpz played a tumor suppressive role in non-small cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xiaoxia, Zhang, Ning, Huang, Yingying, Dou, Xiaojing, Peng, Xiaolin, Wang, Wei, Zhang, Zhe, Wang, Ran, Qiu, Yuling, Jin, Meihua, Kong, Dexin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093516/ https://www.ncbi.nlm.nih.gov/pubmed/33959611 http://dx.doi.org/10.3389/fcell.2021.655559

Ejemplares similares

Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer
por: Fu, Bingjie, et al.
Publicado: (2022)

Targeting c-Jun in A549 Cancer Cells Exhibits Antiangiogenic Activity In Vitro and In Vivo Through Exosome/miRNA-494-3p/PTEN Signal Pathway
por: Shao, Chen, et al.
Publicado: (2021)

STIM1 promotes angiogenesis by reducing exosomal miR-145 in breast cancer MDA-MB-231 cells
por: Pan, Shunli, et al.
Publicado: (2021)

Antiproliferative effect of ZSTK474 alone or in combination with chemotherapeutic drugs on HL60 and HL60/ADR cells
por: Zhou, Qianxiang, et al.
Publicado: (2017)

Macrolide antibiotics enhance the antitumor effect of lansoprazole resulting in lysosomal membrane permeabilization-associated cell death
por: Takeda, Atsuo, et al.
Publicado: (2020)

Stellettin B Induces G1 Arrest, Apoptosis and Autophagy in Human Non-small Cell Lung Cancer A549 Cells via Blocking PI3K/Akt/mTOR Pathway
por: Wang, Ran, et al.
Publicado: (2016)

An important role for peroxiredoxin II in survival of A549 lung cancer cells resistant to gefitinib
por: Kwon, Taeho, et al.
Publicado: (2015)

Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
por: Hwang, Kyu-won, et al.
Publicado: (2008)

Cost-Effectiveness Analysis of Gefitinib Plus Chemotherapy versus Gefitinib Alone for Advanced Non-Small-Cell Lung Cancer with EGFR Mutations in China
por: Shu, Yamin, et al.
Publicado: (2021)

Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis
por: Yi, Min, et al.
Publicado: (2023)

Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR
por: Miyauchi, Eisaku, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Evaluation of Dexlansoprazole Infusion Injection Compared with Lansoprazole in Healthy Chinese Adults
por: Wu, Lihua, et al.
Publicado: (2019)

Immune and Inflammatory Responses in GERD and Lansoprazole
por: Isomoto, Hajime, et al.
Publicado: (2007)

Toxic epidermal necrolysis induced by lansoprazole()
por: Fracaroli, Tainá Scalfoni, et al.
Publicado: (2013)

Alisol B 23-Acetate Inhibits IgE/Ag-Mediated Mast Cell Activation and Allergic Reaction
por: Shao, Chen, et al.
Publicado: (2018)

Terminal differentiation into adipocyte and growth inhibition by PPARγ activation in human A549 lung adenocarcinoma cells
por: Kim, Dae-Young, et al.
Publicado: (2020)

In Vitro Antitumor Activity of Stellettin B, a Triterpene from Marine Sponge Jaspis stellifera, on Human Glioblastoma Cancer SF295 Cells
por: Tang, Sheng-An, et al.
Publicado: (2014)

In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer
por: Ni, Xiao Ling, et al.
Publicado: (2017)

Clinical significance of gefitinib antitumor activity in patients with lung adenocarcinoma
por: WANG, ZHUN, et al.
Publicado: (2015)

Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis
por: Zheng, Dandan, et al.
Publicado: (2021)

EGF Induces Migration Independent of EMT or Invasion in A549 Lung Adenocarcinoma Cells
por: Schelch, Karin, et al.
Publicado: (2021)

Lansoprazole-Induced Improvement of Esophageal Submucosal Injury
por: Mine, Shinichiro, et al.
Publicado: (2007)

The Expression of Heme Oxygenase-1 Induced by Lansoprazole
por: Takagi, Tomohisa, et al.
Publicado: (2009)

Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines
por: Alshetaili, Abdullah S.
Publicado: (2021)

Piceatannol Enhances the Antitumor Efficacy of Gemcitabine in Human A549 Non-Small Cell Lung Cancer Cells
por: Xu, Bin, et al.
Publicado: (2015)

DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
por: Wang, Zhengming, et al.
Publicado: (2018)

Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
por: Wang, Zhengming, et al.
Publicado: (2020)

Plasmodium Circumsporozoite Protein Enhances the Efficacy of Gefitinib in Lung Adenocarcinoma Cells by Inhibiting Autophagy via Proteasomal Degradation of LC3B
por: Lu, Xiao, et al.
Publicado: (2022)

CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer
por: Cao, Yingying, et al.
Publicado: (2021)

Spinacetin Suppresses the Mast Cell Activation and Passive Cutaneous Anaphylaxis in Mouse Model
por: Ji, Ning, et al.
Publicado: (2018)

Synergistic Antitumor Effect of Oligogalacturonides and Cisplatin on Human Lung Cancer A549 Cells
por: Huang, Cian-Song, et al.
Publicado: (2018)

Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells
por: Koyama, Satoshi, et al.
Publicado: (2015)

Lentivirus-mediated silencing of CNTN1 enhances gefitinib sensitivity by reversing epithelial-mesenchymal transition in lung adenocarcinoma A549 cells
por: Hu, Chun-Sheng, et al.
Publicado: (2021)

Toxic epidermal necrolysis induced by Lansoprazole: Pharmacologic considerations*
por: Gomes, Ciro Martins
Publicado: (2013)

Lansoprazole is an antituberculous prodrug targeting cytochrome bc(1)
por: Rybniker, Jan, et al.
Publicado: (2015)

Ingestibility and Formulation Quality of Lansoprazole Orally Disintegrating Tablets
por: Chono, Sumio, et al.
Publicado: (2016)

Lansoprazole as an uncommon cause of anaphylaxis: What to give next?
por: Aydin, Ali Attila, et al.
Publicado: (2018)

In Vitro and in Vivo Antitumor Activity of Scutebarbatine A on Human Lung Carcinoma A549 Cell Lines
por: Yang, Xiao-Kun, et al.
Publicado: (2014)

Atorvastatin Exerts Antileukemia Activity via Inhibiting Mevalonate-YAP Axis in K562 and HL60 Cells
por: Zhang, Lei, et al.
Publicado: (2019)

Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line
por: Sherif, Abdelrahman Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tdf1qe0pcj1uuc66nj4kimohu5